Blueprint Medicines Revenue 2014-2024 | BPMC

Blueprint Medicines revenue for the twelve months ending September 30, 2024 was $0.434B, a 100.93% increase year-over-year.

  • Blueprint Medicines annual revenue for 2023 was $0.249B, a 22.22% increase from 2022.
  • Blueprint Medicines annual revenue for 2022 was $0.204B, a 13.3% increase from 2021.
  • Blueprint Medicines annual revenue for 2021 was $0.18B, a 77.31% decline from 2020.

Blueprint Medicines Revenue 2014-2024 | BPMC

  • Blueprint Medicines annual revenue for 2023 was $0.249B, a 22.22% increase from 2022.
  • Blueprint Medicines annual revenue for 2022 was $0.204B, a 13.3% increase from 2021.
  • Blueprint Medicines annual revenue for 2021 was $0.18B, a 77.31% decline from 2020.